This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Aaron Cowley, PhD
Chief Scientific Officer at ReciBioPharm
Speaker

Profile

Aaron B. Cowley is the Chief Scientific Officer at ReciBioPharm where he provides scientific/technical oversight. He has more than 20 years of experience in discovering and developing manufacturing processes for enzymes and live biotherapeutics, and in developing, optimizing, and qualifying bioassays as well as protein engineering, gene cloning, recombinant protein expression by E.coli, fermentation, protein purification, elucidation of protein structures (NMR and X-ray crystallography), and drug discovery in both research laboratories and industrial settings. He has coauthored over 18 papers and several patents. He has been the Principal Investigator or Co-Principal Investigator on six grants, totaling ~$90M in total funding.

Agenda Sessions

  • Our Progress in Taking xRNA Manufacturing Digital

    7:30am